Neuromuscular Disorders
Volume 22, Issue 1 , Pages 13-15 , January 2012

Amyloidosis and exercise intolerance in ANO5 muscular dystrophy

  • Margherita Milone

      Affiliations

    • Department of Neurology, Mayo Clinic, Rochester, MN, USA
    • Corresponding Author InformationCorresponding author. Address: Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Tel.: +1 507 538 1037.
  • ,
  • Teerin Liewluck

      Affiliations

    • Department of Neurology, Mayo Clinic, Rochester, MN, USA
  • ,
  • Thomas L. Winder

      Affiliations

    • PreventionGenetics, Marshfield, WI, USA
  • ,
  • Paolo T. Pianosi

      Affiliations

    • Department of Pediatrics, Mayo Clinic, Rochester, MN, USA

Received 10 May 2011 ,Revised 1 July 2011 ,Accepted 8 July 2011.

  • Image Result

    Patient’s biopsy of the vastus lateralis muscle. Congo red stained sections visualized under rhodamine optics (A and B) and light microscopy (C) reveal amyloid deposits within the blood vessel walls (

    Patient’s biopsy of the vastus lateralis muscle. Congo red stained sections visualized under rhodamine optics (A and B) and light microscopy (C) reveal amyloid deposits within the blood vessel walls (A, B, C; arrows) and around muscle fibers (B; asterisk). Immunoreactivity for dysferlin was observed in blood vessel walls independently from the presence of amyloid deposits (D).

  • Image Result
    Schematic representation of human ANO5 and location of the disease-causing mutations. ANO5 has eight transmembrane domains and intracellular N- and C-terminals. The resulting phenotypes are indicated

    Schematic representation of human ANO5 and location of the disease-causing mutations. ANO5 has eight transmembrane domains and intracellular N- and C-terminals. The resulting phenotypes are indicated in parentheses next to each mutation (dMD=distal muscular dystrophy; GDD=gnathodiaphyseal dysplasia; LGMD2L=limb girdle muscular dystrophy 2L). The arrows indicate the mutations detected in our patient.

PII: S0960-8966(11)01309-5

doi: 10.1016/j.nmd.2011.07.005

Neuromuscular Disorders
Volume 22, Issue 1 , Pages 13-15 , January 2012